Roche Pharmaceuticals A/S: Financial statements 2023
CVR: 25230515
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Roche Pharmaceuticals A/S (CVR 25230515) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 761,417,000 and a net result of DKK 36,536,000 compared with DKK 19,560,000 the year before. That is a decrease of 3.1% compared with the year before. The profit margin was 4.8%. Equity in the 2023 report amounted to DKK 139,583,000. The solvency ratio was 39%. The company had 97 employees in the financial year.
- Revenue
- DKK 761,417,000
- Gross Profit
- DKK 145,140,000
- Profit/Loss
- DKK 36,536,000
- Equity
- DKK 139,583,000
- Total Assets
- DKK 357,642,000
- Employees
- 97
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 761.4M | 145.1M | 36.5M | 139.6M | 97 |
| 2022 | 785.6M | 149.1M | 19.6M | 163M | 103 |
| 2021 | 732.8M | 133M | 16.3M | 143.5M | 110 |
| 2020 | 701.9M | 126.9M | 12.3M | 127.2M | 121 |
| 2019 | 718.2M | 126.1M | 21.8M | 159.9M | 121 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Roche Pharmaceuticals A/S has published its annual report for 2022. Revenue came to DKK 785,584,000, and the net result was DKK 19,560,000.
About Roche Pharmaceuticals A/S
Roche Pharmaceuticals A/S is a Danish company of the type Aktieselskab based in København V, founded in 1970. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ROCHE A/S. MEDICINALVARER & KEMIKALIER. The management consists of Carole Hassoun. The board consists of Isabel Marianne Joerin (chair), Carole Hassoun and Ehab Abdelmoneim Youssef Hassan. The company is owned by Roche Holding AG. The company has 96 employees (2026). In 2025, the company reported revenue of DKK 928,824,000 and a net result of DKK 31,319,000 compared with DKK 24,277,000 the year before. Equity in the 2025 report amounted to DKK 195,179,000.